Kicking the habit with Nicorette
NEW YORK First, it’s the first truly “new” product to enter the smoking cessation space in quite some time, featuring a strong point-of-differentiation (convenience packaging; faster efficacy), versus products already in this space.
Second, smoking cessation is about to explode, especially as President Barack Obama last month signed into law the Family Smoking Prevention and Tobacco Control Act of 2009, which cedes regulation of tobacco products to the Food and Drug Administration. The law may not ban cigarettes today, or even tomorrow, but it just placed a product long considered a public-health hazard into the regulatory hands of an agency charged with “protecting the public health by assuring the safety, efficacy and security of [medicines], medical devices, our nation’s food supply, cosmetics and products that emit radiation.”
The Congressional Budget Office predicts the new law will decrease adult smoking by 2%, independent of reductions in use that result from higher excise taxes and public smoking restrictions.
More than half of the close-to 50 million smokers attempt to quit each year — 70% of successful ex-smokers made one or two attempts; 22% made between three and five attempts; and 9% quit six or more times before succeeding.
And finally, earlier this month two prescription-only smoking-cessation drugs will now carry a black-boxed warning around the risk of mental health problems in patients taking the drugs.
New product with new features plus increased smoking cessation regulation plus black-boxed warnings for the more popular prescription smoking-cessation medicines all equals a potential new homerun in the smoking cessation category.
Drug retailers post June figures
NEW YORK Drug store chains Walgreens and Rite Aid each reported June earnings Thursday.
For Walgreens, a combination of more 90-day prescription customers and a shift that added an extra weekday to the June 2009 calendar, helped drive sales up 9 percent for the month, with pharmacy leading the way.
According to the company, the total number of prescriptions filled in comparable stores grew 7.5 percent, including a 1.5 percent increase attributable to more patients filling 90-day prescriptions. Meanwhile, as patients generally fill more prescriptions on weekdays than weekends, the addition of the extra weekday this June, accounted for a 2.2-percentage-point increase in the total number of scripts filled in comparable stores.
The extra scripts helped drive Walgreens’ pharmacy same-stores sales comps up 5.8 percent for the month, this despite being negatively impacted by generic substitutions to the tune of some 4.4 percent for the month.
The calendar shift also helped drive stronger overall comps, with same-store sales up 3.4 percent overall despite a softer seasonal business versus June 2008, which helped keep front-end comps in the negative, down 0.9 percent.
In all, Walgreens generated total sales of more than $5.24 billion for the month of June versus $4.8 billion during the comparable year-ago period.
So far, for the year-to-date Walgreens’ sales fiscal 2009 sales are tracking at nearly $52.87 billion for the first 10 months of its fiscal year 2009, up 7.4 percent from $49.24 billion a year ago.
Meanwhile, fellow drug chain Rite Aid reported same-store sales down 0.6 percent for the month, as a 1.4 percent increase in pharmacy comps was not enough to offset a 4.5-percent drop in front-end comps, for the four weeks ended June 27. And for Rite Aid, the hit from generics proved a bit sharper, shaving 484 basis points from its pharmacy comp numbers, the company stated.
Excluding the impact from the Brooks-Eckerd stores it acquired, same-store sales in core Rite Aid stores would have been flat during the month of June, with front-end comps down 4.4 percent and pharmacy comps up 2.6 percent. Same-store sales at the acquired Brooks Eckerd stores declined 1.8 percent in June, with front-end comps down 5 percent and pharmacy comps down 0.7 percent.
In all, Rite Aid’s total sales decreased 2.5 percent during the month, to $1.97 billion versus $2.02 billion for the same period a year ago. Year-to-date, Rite Aid’s total sales through the first 17 weeks of the company’s fiscal 2010 are down 1.5 percent to $8.48 versus $8.61 the same time a year ago. To date, same-store sales are tracking up 0.3 percent for the year, with a 1.6-percent lift in pharmacy comps feeding a 2.3-percent decrease at the front-end of the store.
Take Care opens new Scottsdale clinic
SCOTTSDALE, Ariz. Walgreens’ clinic division, Take Care Health Systems, announced the addition of its newest clinic here Thursday.
The new clinic, located at the Walgreens store at 7011 East Shea Blvd., in Scottsdale, Ariz., makes No. 19 in the area for Take Care. In all, Take Care currently operates 346 retail-based clinics in 35 different markets.